-
Former orthopedic clinic, owners pay $7.1M settlement over alleged unnecessary knee injections, braces: 4 details
Seven former Osteo Relief Institutes and their owners will pay millions of dollars to settle fraud allegations. - 10/21/19 -
LifeNet Health opens regenerative medicine distribution center featuring orthopedic, neurosurgery products
LifeNet Health opened a regenerative medicine logistics and distribution facility in Indianapolis on Oct. 15. - 10/16/19 -
MedTech recognizes Biologica Technologies as top startup
MedTech Outlook Magazine recognized Biologica Technologies as one of the Top 10 MedTech Startups in 2019. - 10/15/19
-
Emory, Duke & more: 4 facilities participate in $13M clinical trial for knee stem cell treatment
Four medical facilities in the U.S. are engaging in a $13 million clinical trial to study stem cell treatment for osteoarthritis in the knee, reports WKRG. - 10/14/19 -
New Bioventus website provides pain relief info for knee osteoarthritis
Bioventus launched a disease and product information website called OAKneePainRelief.com to provide information on knee osteoarthritis for patients and providers. - 10/10/19 -
Orthocell scaffold sees positive results in orthopedic nerve regeneration trial
Orthocell noted positive interim clinical results for CelGro, its collagen-based scaffold to support tissue growth and repair, reports Small Caps. - 10/9/19 -
The state of BMP in spine surgery today
At the North American Spine Society Annual Meeting, in a Sept. 25 panel session titled "BMP in 2019 – The Biologic Hasn't Changed but the Evidence Has," a group of physicians discussed the state of BMP today. - 10/7/19
-
Vor Biopharma boosts leadership team
Stem cell-focused oncology company Vor Biopharma made a series of appointments to its leadership team. - 10/1/19 -
The Spine Journal publishes DiscGenics research for back pain treatment — 5 insights
The Spine Journal, the official journal of the North American Spine Society, published a DiscGenics study examining preclinical testing for Discogenic Cells, reports OA Online. - 9/24/19 -
Chicago Medical School to honor Dr. Wayne Olan — 4 insights
Rosalind Franklin University's Chicago Medical School recognized Wayne Olan, MD, as a distinguished alumnus. - 9/16/19 -
Royal Biologics launches allograft for spine, neurosurgery
Royal Biologics recently launched the Maxx Ultra Cord with clinical applications in spine and neurosurgery. - 9/16/19
-
Drug company appoints David Schaffer to biologics advisory board — 3 insights
Drug company Catalent named David Schaffer, PhD, to its biologics advisory board. - 9/13/19 -
Google banning stem cell-related ads — 3 insights
Google will no longer allow advertisements for unproven or experimental medical procedures in its search results to prevent clinics from misleading patients, The Verge reports. - 9/12/19 -
4 recent biologics treatments under development
Here are four treatments that are in development in the biologics space: - 9/10/19 -
Companies partner to develop biologics-based lower back pain treatment
Drugmakers Grünenthal and Mesoblast entered into a partnership to develop a biologics-based treatment for chronic lower back pain. - 9/10/19 -
NervGen Pharma readies trials for biologic treatment of spinal cord injury, multiple sclerosis
NervGen Pharma is planning its clinical development strategy for its compound, NVG-291, in spinal cord injury and multiple sclerosis patients. - 9/6/19 -
Lineage Cell Therapeutics earns patent for stem cell-derived spinal cord injury treatment
The U.S. Patent and Trademark Office issued a patent for Lineage Cell Therapeutics' stem cell-derived treatment for spinal cord injury. - 9/4/19 -
University of Minnesota Medical School receives $945K to advance stem cell therapy
Duchenne UK awarded researchers from Minneapolis-based University of Minnesota Medical School $945,000 to advance their work around a stem cell-based therapy to treat Duchenne muscular dystrophy. - 9/4/19 -
Opinion: California Institute for Regenerative Medicine wrong to petition for more money
A column by the right-leaning Independent Institute concerned the California Institute for Regenerative Medicine. - 9/4/19 -
5 stem cell developments in spine, orthopedics
Here are five key developments in stem cell treatments for spine and orthopedics. - 8/23/19